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ABSTRACT
ROLE OF MSA IN IMMUNE EVASION, PERSISTENCE AND PROTEASE
REGULATION IN THE HUMAN PATHOGENIC STRAINS OF
STAPHYLOCOCCUS AUREUS
by Maria Deepa Shanthini Basco
August 2013
Opportunistic pathogens like Staphylococcus aureus on entering the host can stay
colonized at the foci of infection or evade the immune system to disseminate to other
sites. In this study we investigated the regulatory influence of the modulator of sarA
(msa) on immune evasion and host persistence, employing the hospital-acquired strain S.
aureus UAMS-1 and community-acquired strain S. aureus USA300 LAC. In the murine
sepsis model, mutation of the msa gene in LAC showed no change in dissemination of
infection; however, in UAMS-1 a decrease in microbial load was observed in the lungs.
Differential regulation by the msa gene was also observed in the blood survival and
neutrophil assays. Several evasion factors were found to be regulated by msa, namely the
scn, clfA, spa, aur, and sak genes. Interestingly, the combination of factors and the
regulation of these factors differed in the two strains.
S. aureus form biofilms on post-surgical wounds, prosthetic devices, and various
host tissues that are resilient to immunological clearance and antimicrobial treatments.
Biofilm detachment is a stage of biofilm development that aids in metastasis of infection.
Proteases are one of the factors that trigger biofilm detachment. In our study, we
observed msa to regulate proteases of S. aureus strain LAC when they are not in the form
of a biofilm community; however, when they form biofilms the regulatory effect on
ii

proteases by the msa gene is absent. Thus, we show the environment-dependent behavior
of the msa gene.
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CHAPTER I
INTRODUCTION
Staphylococcus aureus
Taxonomic Classification
Domain: Bacteria
Kingdom: Eubacteria
Phylum: Firmicutes
Class: Bacilli
Order: Bacillales
Family: Staphylococcaceae
Genus: Staphylococcus
Species: aureus
Nomenclature
Staphylococcus, discovered back in the 1880s by Alexander Ogston while
studying the cause of pus-formation (Ogston, 1880), is currently one of the most
successful gram positive pathogens. Ogston investigated stained smears obtained from an
abscess under a microscope and observed chains and groups of spherical organisms. He
conducted experiments with the pus obtained from abscesses on guinea pigs and mice,
and confirmed the pus-forming abscesses were caused by the spherical organisms
(Ogston, 1880). In 1881, Ogston published a report describing Staphylococcus (then
referred to as Micrococcus) to cause septicemia as well (Ogston, 1881). In 1882, Ogston
renamed the Micrococci as Staphylococci, deriving its prefix from the greek word
staphyle which meant bunch of grapes. Owing to a golden pigmentation which was
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unique to a group of Staphylococci, Anton J. Rosenbach in 1884 named them
Staphylococcus aureus (aurum in Latin meant golden) (Rosenbach, 1884) (Figure 1).

Figure 1. Quadrant streak of Staphylococcus aureus colonies showing the typical golden
yellow colonies (Hedetniemi & Liao, 2010).
Staphylococci
Staphylococci grow to an average diameter of 0.6–1.2 µm and are non-spore
forming and non-motile. They are facultative anaerobes capable of growing in an aerobic
and anaerobic environment. Staphylococci are highly adaptable microbes, capable of
growing in a pH range of 5 to 9. They are also resistant to desiccation and high salt
concentrations (Graham & Wilkinson, 1992).

Figure 2. Gram staining of Staphylococcus aureus showing grape-like clusters of
staphylococcal cells (Wistreich, 2011).
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The genus of Staphylococcus contains mostly pathogens. S. epidermidis, S.
saprophyticus, S. lugdunensis, S. haemolyticus, S. warneri, S. schleiferi, and S.
intermedius are some of pathogenic members of this genus. Based on the ability to
produce coagulase, bacteria belonging to the genus Staphylococcus are differentiated into
coagulase-positive and coagulase-negative staphylococci. S. aureus is one of the major
pathogens that belong to the coagulase-positive staphylococci. Coagulase-negative
staphylococcus has several pathologically relevant members like S. epidermidis, S.
saprophyticus, S. haemolyticus, and S. sciuri.
S. aureus is commonly found in mammals as part of their normal flora. It is found
usually in the nasal passages, axillae, skin, mouth, and along the gastrointestinal and
vaginal tract (Smith, Noble, Bensch, Ahlin, Jacobson, & Latham, 1982; Williams, 1946,
1963). According to a study conducted by Peacock and colleagues in 2001, 20% of the
population was permanent and 60% were transient nasal carriers of S. aureus (Peacock,
de Silva, & Lowy, 2001). Thus, human beings are good reservoirs of S. aureus. Only
30% of the nasal colonization is permanent, leaving the majority to short-termed
colonization (von Eiff, Machka, Stammer, & Peters, 2001). Different strains of S. aureus
have varying preferential sites of colonization depending on the presence of colonization
and adhesion factors. For instance, community acquired Methicillin Resistant S. aureus
(CA-MRSA) preferentially colonize the skin and throat (Mertz et al., 2007). Colonization
of S. aureus is very important to study, as it is important in the determination of the
transmission of infections and possibly in the treatment regimens.
S. aureus causes superficial skin infections like impetigo, cellulitis, folliculitis,
and severe scalded skin syndrome. When S. aureus invades the blood stream, it causes
bacteremia and infections of the organs in the path of the blood stream like endocarditis,
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osteomyelitis, and septic arthritis. Staphylococcal pneumonia, otitis media, and
meningitis are some of the other clinical manifestations of S. aureus infections. Owing to
the variety of enterotoxins produced, S. aureus is also a major contaminant in the food
industry. S. aureus causes staphylococcal food poisoning with characteristic symptoms of
stomach pain and diarrhea.

A

B

C

Figure 3. Some of the infections caused by S. aureus: (A) a cutaneous abscess1 of S.
aureus (Morgan, 2010), (B) an osteomyelitis infection caused by S. aureus (Antimicrobe,
2010) and (C) an infection of a of subclavian catheter (Griffin & Hamilton, 2010).
Virulence and Immune Evasion Factors
S. aureus codes for an arsenal of virulence factors that are surface contained or
released into the environment. Described below are some of these factors that help in
adhesion, colonization, immune evasion, and infection dissemination.
Protein A is a cell wall associated protein that has multiple virulence-associated
functions. This surface exposed protein competitively binds to the Fc region of
immunoglobulins like IgG, IgA, and IgE (Peterson, Verhoef, Sabath, & Quie, 1977;
Lofdahl, Guss, Uhlen, Philipson, & Lindberg, 1983), thus preventing the staphylococcal
cells from being marked for phagocytosis (Gemmell, Tree, Patel, O’Reilly, & Foster,
1991). Protein A can behave as a superantigen if it interacts with the IgM molecules on
the B-cells (DeDent, McAdow, & Schneewind, 2007; Dossett, Kronvall, Williams, &
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Quie 1969; Romagnani et al., 1981) leading to an increased immune response and more
damage to the host. Menzies and Kourteva in 1998 also revealed the apoptotic effect of
protein A on monocytes and macrophages (Menzies & Kourteva, 1998). Thus, protein A
was proposed to be a very important virulence factor of S. aureus.
MSCRAMMS (Microbial Surface Components Recognizing Adhesive Matrix
Molecules) are surface exposed proteins that are covalently attached to the peptidoglycan
layer. These proteins bind to host surfaces to aid in establishing an infection (Foster &
McDevitt, 1994).
Table 1
Examples of MSCRAMMS

MSCRAMMS

Host protein

Reference

Fibronectin-binding protein
(fnbpA and fnbpB)

Fibronectin

(Flock et al., 1987; Signas et al 1989;
Jonsson, Signas, Muller, & Lindberg
1991; Schwarz-Linek et al., 2003)

Clumping factor (clfA and
clfB)

Fibrinogen

(McDevitt, Francois, Vaudaux, &
Foster, 1994; Bayer, Sullam, Ramos,
Li, Cheung, & Yeaman, 1995)

Collagen adhesion (cna)

Collagen

(Patti et al., 1992; Gillaspy, Lee, Sau,
Cheung, & Smeltzer 1998)
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Figure 4. MSCRAMMs (Microbial Surface Components Recognizing Adhesive Matrix
Molecules) of S. aureus (Garcia-Lara, Masalha & Foster, 2005).
S. aureus synthesizes a capsule (Lee, Xu, Albus, & Livolsi, 1994, Lee, Liang,
Hook, & Brown., 2004b) around itself that protects the bacteria and prevents it from
complement activation and opsonophagocytosis by preventing the neutrophil receptor
from gaining access to the staphylococcal proteins (Thakker, Park, Carey, & Lee 1998;
Nilsson, Lee, Bremell, Ryden, & Tarkowski,1997). Of the 11 capsule serotypes that have
been identified, serotypes 5 and 8 have been found associated with human infections.
Serotypes 5 and 8 are produced in small quantities and have proven to be difficult to
study. Overexpression studies have shown that large quantities of capsule 8 showed
longer persistence of the strains in the blood, liver, and spleen of mice in a sepsis model.
The enhanced capsule production also showed increased resistance to
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opsonophagocytosis (Luong, Sau, Gomez, Lee et al., 2004a, 2004b). S. aureus also
produces several cytotoxins that have the ability to lyse leukocytes, monocytes and RBCs
(Wardenburg, Bae, Otto, DeLeo, & Schneewind, 2007) (Table 2).
Table 2
Cytotoxins produced by S. aureus

Cytotoxins

Role in virulence

References

α – toxin

Lyse red blood cells, platelets,
endothelial and epithelial cells

(Gray & Kehoe, 1984; Patel,
Nowlan, Weavers, & Foster, 1987;
Bhakdi et al., 1988, 1989; Bhakdi
& Tranum-Jensen 1991; Bayer,
Ramos, Menzies, Yeaman, Shen,
& Cheung, 1997)

β – toxin

Lysis of erythrocytes

(Projan, Kornblum, Kreiswirth,
Moghazeh, Eisner, & Novick
1989)

γ – toxin and
Leukocidin

Lysis of leukocytes

(Jayasinghe & Bayley, 2005)

Several enzymatic virulence factors are secreted by S. aureus like proteases,
lipases, and coagulases. Staphylococcus expresses various proteases. Unlike most of the
extracellular secreted enzymes of S. aureus, coagulase is a surface associated enzyme
(Kaida, Miyata, Yoshizawa, Igarashi, & Iwanaga, 1989) that coagulates serum by the
reaction illustrated below (Lowy, 2000).
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Coagulase + Thrombin

Staphylothrombin

Fibrinogen

Fibrin (coagulation)

Figure 5. Schematic representation of the process of coagulation by S. aureus.
For a pathogen like S. aureus to establish an infection in the host, it is essential for
the pathogen to withstand the immunological attack by the host. Thus, S. aureus has
several immune evading mechanisms while encountering the host innate and adaptive
immune system. In this study, the focus is on the evasion of phagocytosis, a common
immune response that clears the host of pathogens and foreign bodies. Listed in Table 3
are some of the evading mechanisms and factors employed by S. aureus at the various
stages of phagocytosis.
Table 3
Immune evading factors produced by S. aureus

Virulence Factors

Mechanism of Evasion

Reference

Preventing Chemotaxis
Chemotaxis Inhibitory
Protein (CHIPs)

Binds to neutrophil receptors for
formyl peptides and C5a. Thus
decreasing chemotaxis.

(de Haas et al.,
2004; Haas et al.,
2004)

MHC Class II analogous
protein/extracellular
adherence protein (Eap)

Competes with lymphocyte-functionassociated antigen (LFA-1) for
binding intercellular adhesion
molecule-1 (ICAM-1). Prevents the
binding of neutrophils with
endothelial cells. Thus inhibiting
chemotaxis and extravasation to the
site of infection.

(Chavakis, T. et
al., 2002)
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Table 3 (continued).

Virulence Factors

Mechanism of Evasion

Reference

Preventing Opsonization
Protein A (Spa)

Competitive binding to Fc region of
immunoglobulin like Ig G, IgA and
IgE. It also reduces the platelet
aggregation

(Uhlen, M.,
Guss, B.,
Nilsson, B.,
Gatenbeck, S.,
Philipson, L.,
Lindberg, 1984;
Lofdahl, Guss,
Uhlen, Philipson
& Lindberg,
1983; Gemmell,
Tree, Patel,
O’Reilly, &
Foster, 1991)

Clumping Factor (ClfA)

Clump together by binding to each
other and the fibrinogen to coat the
cells and causing (1) Inhibition of
opsonin deposition (2) Steric
hindrance for opsonophagocytosis.

(Palmqvist, Patti,
Tarkowski &
Josefsson, 2004)

Capsular polysaccharide
(Cap)

Prevent opsonin deposition, or access
to neutrophil receptors.

(Thakker, Park,
Carey, & Lee
1998; Nilsson et
al 1997)

Staphylokinase (Sak)

Plasminogen activator protein

(Rooijakkers,
van Wamel,
Ruyken, van
Kessel, & van
Strijp, 2005a)

Dissolve fibrin clots
Degrades IgG and C3 (after opsonins
deposition has been initiated)
Binds to defensin (an antimicrobial
peptide)
Staphylococcus
Complement Inhibitor
(SCIN)

Prevents the formation of C3b
formation. Thus, interrupting the
complement activation pathways.

(Rooijakkers et
al., 2005b)
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Table 3 (continued).

Virulence Factors

Mechanism of Evasion

Reference

Escape a Phagosome
α – Hemolysin, γ –
Hemolysin,
Panton-Valentine
Leukocidin,
Leukocidin E/D

Assemble into a heptamer and form a
pore in the membranes of the host
cells.
Escape from endosomes and
phagocytes

(Montoya &
Gouaux, 2003)
(Menestrina et
al., 2003)

Intracellular Survival
Aureolysin (Aur)

Cleaves the antimicrobial peptide
human defensin peptide cathelicidin
LL-37.

(SieprawskaLupa, M. et al.,
2004)

Global Regulation
The synthesis and action of virulence factors are coordinated and controlled by
regulators. These regulators could be transcriptional regulators like Sigma factor B
(Bischoff et al., 2004; Ziebandt et al., 2001), two-component systems like Staphylococcal
accessory element (Sae) (Novick & Jiang, 2003), or RNA molecules like RNA III of the
agr system (Janzon & Arvidson, 1990; Novick, Ross, Projan, Kornblum, Kreiswirth, &
Moghazeh, 1993). Some the well-studied global regulators are the accessory gene
regulator (Agr), staphylococcal accessory element (Sae), and the staphylococcal
accessory regulator (SarA).
The Agr System
The Agr system (accessory gene regulator) was first studied in an agr mutant with
a Tn551 transposon inserted into the agr locus (Mallonee, Glatz & Pattee, 1982; Recsei,
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Kreiswirth, O'Reilly, Schlievert, Gruss, & Novick, 1986). Cloning and characterization of
the agr gene showed the agr locus to code for a two-component system (Peng et al.,
1988). The agr locus consists of two transcripts: RNA II and RNA III that are under the
promoters P2 and P3 respectively. The genes that code for RNA II are the agr B, agr D,
agr C, and agr A, and the proteins coded by them regulate the RNA III production. The
RNA III also codes for the hld, delta hemolysin. The production of RNA III is regulated
by the agrBDCA genes. The agr system plays an important role in the synthesis of
secreted proteins like toxic shock syndrome toxin (TSST-1), hemolysins, serine protease,
and surface-associated proteins like protein A, coagulase, and fibronectin binding protein
(Lindberg et al., 1990).

Figure 6. The agr quorum system of S. aureus. (Camara, Williams, & Hardman, 2002)
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A mutant of the hld gene did not produce an agr mutant, thus was not the effector
of the agr system (Novick et al., 1993). Although when the role of RNA III in an agr
system was studied by introducing a plasmid carrying the gene for RNA III into an agr
strain it produced an agr+ phenotype. The agr complementation was also performed with
a RNA II, which failed to produce an agr+ phenotype. Thus, RNA III was concluded to
be the regulator of agr system. RNA III regulation of transcription and translation of
target genes was independent of each other (Novick et al., 1993). The RNA III was
observed to reach a maximum expression during the post-exponential phase
(Vandenesch, Kornblum, & Novick, 1991).
The Agr A and Agr C are the response regulators and the histidine kinase
components of the two-component system. The Agr C is a 46 kDa transmembrane protein
that consists of a sensor that recognizes AIP and a cytoplasmic transmitter that contains a
histidine residue (Lina et al., 1998). This activation of Agr C is dose-dependent, and the
maximal activation occurs at an optimum concentration of AIP. Activation of Agr C
leads to autoinduction of agrBDCA and the synthesis of RNA III (Ji, Beavis, & Novick
1997). The RNA III acts as the effector of the agr system, which increases transcription
of secreted proteins and decreases transcription of surface proteins. The Agr D consists of
an N-terminal region, followed by the AIP that gets cleaved off on processing and a Cterminal region. Agr B has the endopeptidase activity by which it modifies the Agr D and
secretes the AIP produced out of the cell (Zhang, Gray, Novick, & Ji 2002; Zhang & Ji,
2004; Zhang, Lin & Ji, 2004).
The agr system is classified into agr types I–IV, based on varying regions
(hypervariable regions) (Dufour et al., 2002) in agrBDCA operon and they respectively
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recognize the AIP types I – IV (Ji, Beavis, & Novick, 1997, 1997; Jarraud et al., 2000;
McDowell et al., 2001; Otto, Echner, Voelter, & Gotz, 2001).
The regulatory influence of agr on other genes is imparted by the binding of
AgrA, binding of the RNA III molecule to the virulence genes under regulation or
indirectly through the interaction of RNA III and Rot (repressor of toxins) (Geisinger,
Adhikari, Jin, Ross, & Novick, 2006). Dunman et al., (2001) showed that agr increased
expression of proteases, lipases, ureases, toxins (encoded by hla, hld, and hlb), and
enterotoxins (SEB, SEC and SED) via the binding of RNA III component of the agr
system (Dunman et al., 2001). Other factors regulated by agr are listed in Table 4.
Table 4
Regulation of virulence genes by agr

Genes Positively Regulated by agr

References

α- hemolysin (hla)

(Morfeldt, Taylor, von Gabain &
Arvidson, 1995; Novick et al., 1993;
Xiong et al., 2006)

Aureolysin (aur)

(Oscarsson, Tegmark-Wisell & Arvidson
2006)

Serine Protease (ssp)

(Oscarsson, Tegmark-Wisell & Arvidson
2006)

Staphylokinase (sak)

(Shaw, Golonka, Potempa & Foster,
2004)

Polysaccharide capsule (cap)

(Luong, Sau, Gomez, Lee et al., 2004a,
2004b; Dassy, Hogan, Foster & Fournier,
1993)
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Table 4 (continued).

Genes Negatively Regulated by agr

References

Protein A (spa)

(Novick et al., 1993, Benito, Kolb,
Romby, Lina, Etienne & Vandenesch,
2000)

Coagulase (coa)

(Chevalier et al., 2010)

Fibronectin binding protein (fnb)

(Saravia-Otten, Muller &Arvidson 1997)

The SarA System
The SarA (staphylococcal accessory regulator) is a 124kDa dimeric DNA binding
protein. The sarA locus that codes for SarA has three transcripts sar A, sar B, and sar C
that are produced under three promoters P1, P2, and P3 respectively (Bayer et al., 1996;
Manna, Bayer, & Cheung 1998). The P1 and P2 promoters require the sigma A, while the
P3 promoter requires the sigma B factor (Deora, Tseng, & Misra, 1997; Manna, Bayer, &
Cheung, 1998). This DNA binding protein is expressed in the mid- and late-exponential
phase of growth (Rechtin et al., 1999; Bayer et al., 1996).
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Figure 7. The sarA system and the influence of SarA on other genes. (Cheung & Zhang,
2001)

In in vitro studies, Sar A has been observed to bind to several promoter regions of
genes like hla, fnA, and fnB and upregulate them (Cheung, Koomey, Butler, Projan, &
Fischetti, 1992; Cheung & Ying, 1994, Wolz et al., 2000). The sar A however, downregulates expression of genes like the serine protease (SspA) and cysteine protease
(ScpA) (Lindsay & Foster, 1999). The ica gene locus encodes the PIA (Polysaccharide
Intercellular Adhesin) biosynthesis. This gene locus consists of the ica A, ica D, ica B,
and the ica C genes along with the negative regulator ica R. The ica A promoter and the
ica R are regulated by the sar A (Tormo et al., 2005b).
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Pathogenesis
S. aureus are opportunistic pathogens that cause a variety of infections once they
gain access to the host through hair follicles, open skin of cuts, incisions, injections,
wounds, surgical wounds, or in-dwelling catheters. The infections caused by S. aureus
range from localized superficial infections like abscesses, impetigo, and carbuncles to
invasive infections like septic arthritis, osteomyelitis, and endocarditis (Figure 7) (Lowy,
1998).
S. aureus is one of the major causative agents of the gram-positive mediated
sepsis. It is not the infecting pathogen by itself but the excessive host immunological
response to this invader that causes the increased damage to the host (Angus et al., 2001).
In an epidemiology study conducted on the incidence of sepsis from 1979 to 2000, S.
aureus was reported to be the causative agent responsible for 52% of the cases (Martin,
Mannino, Eaton, & Moss, 2003). Angus et al. (2001) reported a sepsis-associated
mortality percentage of about 30, which increased to 40% with senior citizens in spite of
being under hospital care and antibiotic treatment. Of this percentage, 40 % was incurred
by gram positive infections (Angus et al., 2001; Alberti et al., 2002).
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Figure 8. Pathogenesis model of S. aureus (Clark & Company, 1998)
S. aureus is subject to attack by both the innate and acquired immune system. On
entering the host, S. aureus can establish an infection either at the site of entry, or if it
evades the immune system it could even cause severe systemic infections (Table 5).
Infection leads to inflammation that signals phagocytes to the site. These phagocytes
secrete antimicrobial substances to kill the bacteria as well as secrete signals to attract
more phagocytes (chemotaxis) to the site of infection to clear the pathogens. The
outcome of the immunological attack decides the fate of the staphylococcal invasion.
This determines the extent of infection dissemination and severity. The other factors that
ease the establishment of a staphylococcal infection are age and compromised immune
systems.
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Table 5
Some of the sites of infections caused by S. aureus

Sites for Infections

S. aureus infected

Skin and Soft Tissue Infections
(SSTIs)

76% of total purulent SSTIs in 11 emergency
departmentsa

In-dwelling Device Infections

7.3% of all S. aureus infectionsb

Post-surgical Infections

10.1% of all S. aureus infectionsb

Urinary Tract Infections

3.6% of all S. aureus infectionsb

Note. a – In 2004 (Moran et al., 2006); b – In 1999 – 2000 (Kuehnert, et al., 2005)

Methicillin Resistant Staphylococcus aureus (MRSA)
Methicillin Resistant Staphylococcus aureus are S. aureus that have the ability to
build resistance to most antibiotics like the penicillins–flucloxacillin, oxacillin, and
methicillin. Methicillin was the antibiotic used to treat penicillin resistant S. aureus
infections in the past until the 1960s when the first case of MRSA was found in the
United Kingdom (Jevons, 1961). In a study conducted with data from 1,268 ICU sections
of 337 hospitals from 1992 to 2003 alone, the MRSA positive infections increased from
35.9% to 64.4% among the S. aureus isolates (Klevens et al., 2006). Based on the
statistical information by the Centers for Disease Control and Prevention of the S.aureus
and MRSA Surveillance Summary 2007 in the US, there have been 292,000 cases of
hospitalizations that are positive for S. aureus infections annually (Kuehnert et al., 2005).
MRSA infections cause a large degree of stress on the healthcare sector owing to
its high mortality rate, lack of treatment success, and cost. Several types of genotypic
typing have been conducted ever since the realization of the endemic spread of MRSA
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infections. Some of the methods used to classify the various S. aureus isolates are
classifications by antibiotic susceptibility, any phenotypic characteristic, sequence of spa
gene that encodes for the Protein A, Pulsed-field gel electrophoresis (PFGE, DNA-based
finger printing method), and Multilocus Enzyme Electrophoresis (MLEE). These
methods were soon taken over by Multilocus sequence typing (MLST). Genotypic typing
comparisons of the first MRSA isolate in the UK in 1961 and the MSSA that were
prevalent in Denmark in the 1950s revealed no difference (Crisostomo, Westh, Tomasz,
Chung, Oliveira, & Lencastre, 2001) except for the mobile genetic element
Staphylococcal Cassette Chromosome – SCCmec (Katayama, Ito, & Hiramatsu, 2000).
The SCCmec element carries the mecA gene that codes for the PBP 2’ or PBP2a
(Penicillin binding protein 2’), which confers antibiotic resistance to β-lactam antibiotics
(Hartman & Tomasz, 1984; Reynolds & Brown, 1985; Utsui & Yokota, 1985).
Crisostomo and group thus suggested that MRSA strains might have descended from
MSSA isolates (Crisostomo et al., 2001). Unlike HA-MRSA SCCmec types of I–III, CAMRSA strains carry the SCCmec type IV (Okuma et al., 2002, Vandenesch et al., 2003).
While most infections were found associated with individuals who have had a
prior exposure to the healthcare setting or have been in close contact with other
individuals (Saravolatz, Markowitz, Arking, Pohlod, & Fisher, 1982a; Saravolatz,
Pohlod, & Arking, 1982b; Thompson, Cabezudo, & Wenzel, 1982; Boyce, 1998;
Graffunder & Venezia, 2002; Lodise, McKinnon, & Rybak, 2003), Community
Acquired-MRSA infections were found in individuals who have had no prior encounters
to the clinical setting or any pre-disposing factors (Crum et al., 2006; Naimi et al., 2003).
In an epidemiological study conducted from July 2004 to December 2005 in the US, it
was reported that of the invasive infections recorded, 58.4% of them were community
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onset HA-associated, 26.6% hospital onset HA-acquired, and 13.7% were CA-MRSA
infections (Klevens, Morrison, & Nadle, 2007).
Hospital-Acquired Staphylococcus aureus
Based on the epidemiologic classification of invasive MRSA infections, health
care associated MRSA infections were classified into two types: (a) community onset and
(b) hospital onset. Community onset heath care-associated MRSA infections were
defined as “cases with at least 1 of the following health care risk factors: (1) presence of
an invasive device at time of admission; (2) history of MRSA infection or colonization;
(3) history of surgery, hospitalization, dialysis, or residence in a long-term care facility in
previous 12 mo preceding culture date” (Klevens et al., 2007, p. 1765). Hospital onset
health care-associated MRSA infections were defined as “Cases with positive culture
result from a normally sterile site obtained >48 h after hospital admission. These cases
might also have ≥1 of the community-onset risk factors” (Klevens et al., 2007, p. 1765).
In a study conducted between the years 1992–2003, HA-MRSA causing infections
reached a high percentage of 64.4% of the infections of intensive care units in the US
(Klevens et al., 2006). Based on the antibiotic resistance gene, the type of recombinase
gene and the number of them, the SCCmec are classified into five classes (Ito et al.,
2002; Okuma et al., 2002). SCCmec found in HA-MRSA isolates are SCCmec I-III (Ito
et al., 2001; Enright et al., 2002). The PFGE types USA100, USA200, and USA500 are
common among HA-MRSA infections.
Community-Acquired Staphylococcus aureus
Based on the epidemiologic classification of invasive MRSA infections, cases of
community-acquired infections were defined as “cases with no documented communityonset health care risk factor” (Klevens et al., 2007, p. 1765). Community-acquired
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MRSA strains were first reported in 1981 in Detroit among intravenous drug abusers
(Saravolatz et al., 1982a). Mortality-associated CA-MRSA infections were soon reported
a few years later in 1997 in Minnesota and North Dakota (CDC, 1999). In 2006, Moran,
et al. published evidence of CA-MRSA causing SSTIs in emergency departments. CAMRSA reported had a diverse prevalence from children under child care (Adcock, Pastor,
Medley, Patterson, & Murphy, 1998), to sports members (CDC report 2003; Begier et al.,
2004), to correctional facilities (CDC, 2003). Infections among the community without
prior exposure to a health setting was not the only alarming feature of CA-MRSA
infections, these SSTI causing strains also caused severe, invasive infections that have
been morbidity-associated ones (Naimi et al., 2003; Zetola, Francis, Nuermberger, &
Bishai, 2005; Kaplan et al., 2005; Fridkin et al., 2005).
Unlike most strains of S. aureus, CA-MRSA strains reside relatively longer on the
human skin than in the nasal passages (Mertz et al., 2007; Shurland et al., 2007). This site
of colonization makes pathogens like CA-MRSA very accessible for transmission, which
could be one of the contributing factors to the contagiosity of CA-MRSA infections
(Nguyen, Bancroft, Mascola, Guevara, & Yasuda, 2007).
Pulse-field gel electrophoresis (a RFLP based technique) is one the most common
and established modes of local-level genotypic typing followed in the United States. The
Center for Disease Control and Prevention identified two notorious clones of CA-MRSA
strains prevalent in the US by PFGE: USA300 and USA400 (McDougal et al., 2003). The
USA300 PFGE type (Tenover et al., 2006) was among the most pathogenically dominant
CA-MRSA strains (Li et al., 2009). The other PFGE types associated with the CA-MRSA
strains were USA400, USA1000, and USA1100 (McDougal, Wenming, Patel & Tenover,
2004).
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Strains of USA300 are MRSA (Diep et al., 2006). Presence of the genes of
Panton-Valentine leukocidin (PVL), enterotoxin Q, enterotoxin K, and arginine catabolic
mobile element (ACME) are unique to the USA300 strains (Diep et al., 2006). The
ACME is a 30.9 kb acquired genetic element that carries the arc gene cluster. The arc
gene cluster codes for the enzymes required for conversion of L-arginine to metabolically
important products like ATP, carbon-dioxide, and ammonia. Nitric oxide (NO) is an
important player in the immune system of the host; thus, unavailability of L-arginine, the
precursor of NO, is believed to aid in surviving the hostile immunological attacks on
bacteria (Diep et al., 2006; Degnan et al., 1998, 2000).
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CHAPTER II
BACKGROUND
The msa Gene
While screening using a Tn551 library, a novel gene was identified to be involved
in the regulation of sar A – the msa (Modulator of sar A) gene. Mutation of this msa gene
has been seen to affect the expression of sar A and several virulence-related genes in the
S aureus strains COL, RN6390, and UAMS-1 (Sambanthamoorthy, Smeltzer, & Elasri,
2006) (Table 2.1). The mutant of msa was also observed to be unable to form mature
biofilms, a hallmark feature of S. aureus. (Sambanthamoorthy, Smeltzer, & Elasri, 2006;
Sambanthamoorthy, Schwartz, Nagarajan, & Elasri, 2008).
Table 6
Genes previously known to be regulated by msa

Extracellular factors

Surface factors

α-hemolysin(hla)

Clumping factor A (clfA)

Aureolysin (aur)

Protein A (spa)

V8 proteases(ssp)

Collagen adhesin (cna)

Lipase (lip)

Fibronectin (fnb)

The sequence of the msa sequence was analyzed by computational analysis and
predicted to be a 15.67kDa transmembrane protein with three transmembrane regions.
The positions of the potential phosphorylation sites further suggested that the Msa protein
could be a membrane protein functioning as a signal transducer (Nagarajan & Elasri,
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2007). Additional research on the msa mutant by microarray analysis showed that the
msa gene regulated several genes (unpublished data) which, strongly suggested that the
msa gene could be a global regulator like sarA or the agr system. At the amino acid level,
the Msa sequence shows homology and conservation across several strains like RF122,
MRSA252, MSSA476, MW2, COL, Mu50, N315, and NCTC 8325 (Nagarajan & Elasri,
2007).
Strain S. aureus UAMS-1
The S. aureus strain UAMS-1 was isolated from an osteomyelitis patient from the
McClellan Veterans Hospital in Little Rock, Arkansas (Gillaspy et al., 1995). Animal
model studies have shown UAMS-1 strains to be very proficient in osteomyelitis and
septic arthritis (Blevins et al., 2003; Smeltzer et al., 1997). UAMS-1 strains of S. aureus
are methicillin susceptible, host acquired strains (Gillaspy et al., 1995). The α-hemolysin
gene, hla of UAMS-1 carries a nonsense mutation thus UAMS-1 is unable to synthesize
the toxin (Cassat et al., 2006) but this has not influenced the pathogenicity of UAMS-1
strains. UAMS-1 strain was used for this study as a representative of a hospital acquired
strain.
Strain S. aureus USA300 – 0114 LAC
Most clinically relevant strains belonging to the PFGE type USA300 are of the
subtype USA300-0114 (McDougal et al., 2003; Tenover et al., 2006). The USA300 strain
FPR3757 was isolated from an abscess on the wrist of a HIV-positive male at the San
Francisco General Hospital (Pan et al., 2005). This strain was used in this study as a
representative of a community acquired clinical isolate.
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Comparison of S. aureus Community-Acquired Isolate USA300 LAC vs HospitalAcquired Isolate UAMS-1
The regulatory role of the msa gene was studied in the genetic backgrounds of
LAC and UAMS-1. Here, a comparison was made between these two strains to
understand the behavior of the msa gene in these two genetic backgrounds. Nagarajan et
al. showed conservation of the msa gene across very strains of S. aureus, yet the
regulatory behavior of the msa gene has showed variations across these strains
(Nagarajan & Elasri, 2007; Sambanthamoorthy, Smeltzer, & Elasri, 2006). Thus, to better
understand the regulation by the msa gene in the strains of S. aureus, previous findings
on the genetic content of LAC and UAMS-1 were gathered and compared in Table 7.
Table 7
Comparison of S. aureus community acquired isolate USA300 LAC vs hospital acquired
isolate UAMS-1

USA300 LAC

References

First
isolated

Abscess isolate,
USA, 2000

(Diep et al.,
2006)

PFGE

USA300 (subtype (Kennedy et
0114)
al., 2005,
Francis et al.,
2005, Miller et
al., 2005)

UAMS-1

Bone isolate from a
Osteomyelitis
patient, Little Rock,
AR, 1995
USA200

References

(Gillaspy
et al.,
1995)

26
Table 7 (continued).

USA300 LAC

References

UAMS-1

References

MLST

ST8

(Enright et al., ST30
2000, Miller et
al., 2005)

(Cassat et
al., 2005)

Spa type

YHGFMBQBLO,
spa1

(Shopsin et
al., 1999,
Miller et al.,
2005)

WGKAKAQ,
spa33

(Cassat et
al., 2005)

SCCmec

SCCmec Iva

(Ma XX et al.,
2002,
Robinson et
al., 2005,
Miller et al.,
2005)

None

(Gillaspy
et al.,
1995)

Methicillin
MRSA
susceptibility

(Diep et al.,
2006)

MSSA

(Gillaspy
et al.,
1995)

Agr
subgroub

Type I

(McDougal et
al., 2003)

III

(Cassat et
al., 2005)

ACME

Present (Type I)

(Diep et al.,
2006)

Absent

(Zhu et al.,
2007; Fey
& Olson,
2010)
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CHAPTER III
DELETION OF THE MSA GENE
Introduction
Previous to this study, the role of msa was studied using an insertional mutant
which, provided good evidence that msa is required in regulating virulence and biofilm
formation (Sambanthamoorthy, Smeltzer, & Elasri, 2006; Sambanthamoorthy, Schwartz,
Nagarajan, & Elasri, 2008). But, insertional mutants have several disadvantages. There is
always a possibility of a truncated product being formed due to the upstream part of the
open reading frame in question being intact. Additionally, if the gene is part of an operon,
the insertional mutation can hamper the transcription of the neighboring genes. Taking all
these potential polar effects of insertional mutants into consideration, the msa gene was
mutated by deletion.
A temperature sensitive shuttle vector pKOR1 was used to delete the msa gene
from S. aureus strains COL, LAC, RN6390, and UAMS-1. At the non-permissive
temperature of 43˚C, pKOR1 integrates into the chromosome and at 30˚C, which is the
permissive temperature the plasmid eviction is favored. This eviction facilitates the loss
of the msa gene. One of the special features of pKOR1 is that it offers an inducible
counter selection with anhyrotetracycline (ATc) that selects for chromosomal excision
and loss of plasmid without the use of an antibiotic.
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Figure 9. Schematic representation of the temperature sensitive pKOR1 vector employed
to create deletion mutants of S. aureus. Labels indicated: attP sites = attachment sites P1
and P2, cat sites = chloramphenicol resistance sites for gram positive [cat (+)] and gram
negative [cat (-)] hosts, bla = ampicillin resistance gene, tetR = tetracycline resistance
gene, Pxyl/tetO = promoter producing the antisense product for the protein required for
protein translocation.

Figure 10. Schematic representation of the insert preparation containing the Upstream
and Downstream regions of msa gene to be inserted into the pKOR1 vector.
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Materials and Methods
Bacteria and Growth Conditions
The bacterial strains of Staphylococcus aureus were grown in Tryptic Soy Broth
(TSB) and Tryptic Soy Agar (TSA) at the required temperatures and in the presence of
appropriate antibiotics. The plasmid pKOR1 was used to delete the msa gene from the
chromosomal DNA. The pKOR1 transformations were carried out in Escherichia coli
and S. aureus RN4220. The Phage φ11 was also employed to transfer pKOR1 from S.
aureus RN4220 to the strains of S. aureus COL, USA300 LAC (Los Angeles county
clone), RN6390, UAMS-1.
Allelic replacement with pKOR1
The gene msa in S. aureus strains were mutated by deletion using the mutagenesis
protocol described by Bae and Schneewind (Bae & Schneewind, 2006). Briefly, the
flanking regions of the msa gene were amplified from Staphylococcus aureus with
primers listed in Table 8 by PCR. The DNA fragments isolated were digested with the
restriction enzyme BamHI and ligated using T4 DNA ligase. This ligated fragment was
amplified using the F-UR and R-DR primers and was inserted into pKOR1 using the
Gateway BP Clonase Enzyme Mix (Invitrogen’s Corp.). The plasmid thus formed
pKOR1-∆msa was introduced into TOP 10 cells (Invitrogen’s Corp.) by chemical
transformation and then into S. aureus RN4220 by electroporation. The plasmids isolated
were verified by sequencing and transferred into the respective strains of S. aureus by φ
11-mediated phage transduction. The plasmids isolated were again verified by PCR and
sequencing.
S. aureus strain containing the pKOR1-∆msa was cultured overnight in TSB at
30˚C in the presence of chloramphenicol (7.5µg/ml). A plate of TSA containing
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chloramphenicol (7.5µg/ml) was streaked with the overnight culture and incubated at
43˚C overnight. The colonies thus formed were picked and inoculated in plain TSB and
allowed to grow overnight at 30˚C. The following day a dilution of 10-4 were prepared
from the overnight cultures and plated on TSA containing 100ng/ml of
anhydrotetracycline. This temperature shift from 30˚C to 43˚C was repeated once more.
The colonies thus formed were picked and streaked on both plain TSA and TSA
with chloramphenicol. The colonies that grew only on TSA plates were selected and
analyzed for mutation of the msa gene. The co-integration protocol followed is as
described by Bae and Schneewind (2006).
Table 8
Primers used for isolating the flanking regions of the msa gene

Regions

Upstream
Region (UR)

Downstream
Region (DR)

Primer

Sequence

F-UR

GGGGACAAGTTTGTACAAAAAAGCAGGCTCTGCGTCA
TCCCCTTG

R-UR

ATTAGGATCCAACAACGTTTGCAGCTTGTG

F-DR

TGTTGGATCCTGGTATGTATATGATGCT

R-DR

GGGGACCACTTTGTACAAGAAAGCTGGGTTACCAT
CGCGCATTTA

Note. Region in italics are the att sites and the region underlined the Restriction site of BamHI.

Verification of the Deletion Mutant
The mutants of msa were verified by the following methods:
(1) PCR: In order to verify the mutation of the msa gene from the chromosome of S.
aureus, chromosomal DNA was isolated from the potential mutants and tested by
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PCR using the (A) F-UR and the R-DR primers (Figure 11) and (B) the msa open
reading frame primers.
(2) Sequencing: The regions amplified by PCR using the F-UR and R-DR primers
were cloned into pCR2.1 (TOPO vector, Invitrogen Inc.). These vectors were sent
for sequencing with F-UR, R-DR primers, and the F-UR-SEQ primer.

Figure 11. Schematic representation of the expected msa mutation.
Complementation
The open reading frame of msa along with the upstream region containing the
msa promoter was inserted into pLi50 and introduced into the msa mutant strains to serve
as the complement. Since, pLi50 was a high copy number vector, complementation was
also attempted with a low copy vector pCN34 (requested from NARSA).
Phenotypic Characterization
Biofilm assay.A 20% solution of human plasma was prepared and 200µl of this
solution was added to the wells of a microtiter plate and incubated at 4˚C to coat the
wells. The next day the plasma was carefully aspirated and the wells were washed thrice
with 1X PBS. Overnight cultures of the testing strains were normalized (with TSB
containing 3% NaCl and 0.5% glucose) and added to the respective wells. The plates
were incubated at 37˚C. The contents of the wells were aspirated and washed with 1X
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PBS. Following washing, 100% of ethanol was used for fixing (10 min) and crystal violet
for staining (2 min). The stain was washed with PBS and the plate was allowed to dry
overnight inverted.
Protease assay. The strains were grown overnight in TSB at 37˚C. The following
day 300µl of the culture supernatant was filtered and incubated overnight at 37˚C with
800 µl of Azocasein (3mg/ml) in Tris buffered saline (pH 7.5). The undegraded azocasein
was precipitated by 50% trichloroacetic acid and the protease activity was assayed by
measuring the amount of acid-soluble azocasein spectrophotometrically at 340 nm
(Smeltzer et al., 1993).
Hemolytic assay.The strains were grown in TSB at 37˚C with shaking at 120
rpm. The following day, the cultures were normalized to the lowest OD at 560nm.
Supernatants were collected and filtered. Ten microliters of supernatant was mixed with
1ml of 2% rabbit blood in 10mM Tris HCl (pH 7.5) – 0.9% NaCl. This was incubated at
37˚C for 15 minutes. The lysed cells were separated from the supernatant and the
supernatant was used to measure optical density (OD) at 405nm. TSB and 1% SDS were
used as negative and positive controls respectively (Blevins et al., 2002).
Results
Mutants of S. aureus strains LAC, UAMS-1, RN6390 and COL were verified as
described. Figure 12 shows the absence of the msa gene in the mutant strains of S.
aureus. Individual strains of LAC, UAMS-1 and COL were also verified by the ACME
region (Figure 13), cna gene (Figure 14), and tetracycline resistance (Figure 3.7)
respectively.
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1 = LAC
2 = LAC Δmsa
3 = UAMS-1
4 = UAMS-1Δmsa
5 = RN6390
6= RN6390Δ msa
7 = COL
8 = COL Δmsa
Figure 12. PCR with msa primers to verify the deletion of the msa gene in the S. aureus
strains of LAC, UAMS-1, RN6390, and COL.

1 = LAC
2 = LAC Δmsa
3 = UAMS-1
4 = UAMS-1Δmsa
5 = RN6390
6= RN6390Δ msa
7 = COL
8 = COL Δmsa

Figure 13. PCR with primers specific for the ACME region (unique for USA300 LAC
strains) to confirm the genetic background of S. aureus LAC strains.
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1 = LAC
2 = LAC Δmsa
3 = UAMS-1
4 = UAMS-1Δmsa
5 = RN6390
6= RN6390Δ msa
7 = COL
8 = COL Δmsa

Figure 14. Verification by PCR of S. aureus UAMS-1 (unique for UAMS-1 strain) by the
presence of the cna gene of S. aureus UAMS-1 strains.

Figure 15. Tetracycline test with S. aureus COL strains confirming the strains of S.
aureus COL strains.
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Growth Curve
Growth curves of the strains of S. aureus LAC and UAMS-1 strains showed that
deletion of the msa gene did not affect the growth of the strains (Figures 16 and 17).

Figure 16. Growth Curve of S. aureus UAMS-1 strains showing that the deletion of the
msa gene of S. aureus UAMS-1 does not influence the viability of S. aureus UAMS-1.

Figure 17. Growth Curve of S. aureus LAC strains strains showing that the deletion of
the msa gene of S. aureus LAC does not influence the viability of S. aureus LAC.
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Phenotypic Characterization
Biofilm Assay. Wild type strains of S. aureus COL have the ability to produce
biofilms and Sambanthamoorthy et al. (2006, 2008) showed that insertional mutation of
msa reduced the biofilm formation. These previous findings matched the observations of
the biofilm assay with the deletion mutants of S. aureus COL (Figure 18).

Figure 18. Biofilm Assay of S. aureus COL strains showing the weak biofilm fomation in
the msa mutants. Control wells contained uninoculated media to represent negative
controls.

Protease assay. Protease activity of S. aureus COL was also assessed and showed
that deletion of the msa gene increased the protease activity of the strains (Figure 19).
This phenotype was also observed in the insertional mutants of S. aureus COL
(Sambanthamoorthy, Smeltzer, & Elasri, 2006).
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Figure 19. Protease Activity of S. aureus COL strains showing increased protease
activity in the msa mutants compared to the wild type strains. Un-inoculated media was
used as a negative control.
Hemolytic assay. Deletion of the msa gene reduced hemolytic activity of the S.
aureus COL strain. The reduced hemolytic activity of the deletion mutants of S. aureus
COL (Figure 20) were similar to that observed by Sambanthamoorthy et al. (2006).

Figure 20. Hemolytic Assay of S. aureus strains of COL showing reduced hemolytic
activity on deleting the msa gene. Un-inoculated media and 2% SDS solution were used
as a negative and positive control, respectively.
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Discussion
The msa gene was successfully deleted from the S. aureus strains of COL,
USA300 LAC, UAMS-1, and RN6390. Phenotypic characterizations observed with the
msa mutant of COL were similar to that of the insertional mutants (Sambanthamoorthy,
Smeltzer, & Elasri, 2006; Sambanthamoorthy, Schwartz, Nagarajan, & Elasri, 2008).
Further studies on virulence and immune evasion were conducted with mutants in
the USA300 LAC and UAMS-1 strains. Hence, to ensure the mutation of msa did not
affect the viability of the strains, growth of the wild type was monitored along with the
mutant. As seen in Figures 16 and 17, mutation of msa did not affect the growth and
viability of the strains. Thus, the deletion mutants of the msa gene were employed to
explore the features of global regulation in S. aureus.
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CHAPTER IV
MSA REGULATES IMMUNE EVASION, HOST PERSISTENCE AND
DISSEMINATION IN THE CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS
Abstract
Staphylococcus aureus is an opportunistic pathogen residing usually on the skin
and nasal passages of humans. On gaining entry into the host, S. aureus has the ability to
colonize and cause localized infections or spread and infect organs on the path of
dissemination. The msa gene of S. aureus has been previously observed to regulate
several virulence genes. Here in this study, we examined the influence of the msa gene on
the regulation of immune evasion, host persistence, and dissemination employing the
hospital-acquired strain S. aureus UAMS-1 and community-acquired strain S. aureus
USA300 LAC. The murine sepsis model used to study host persistence and
dissemination, showed that deleting the msa gene of UAMS-1 decreased the microbial
surviving load in the lung, whereas the mutation in LAC showed no change in
dissemination and colonization. The msa mutant in UAMS-1 also showed a decrease in
survival in blood and in phagocytic-intracellular survival while in LAC the mutation
showed no deterrence. On investigating the immune evasion factors regulated by the msa
gene, we found significant fold changes in the expression of the scn, clfA, spa, aur and
sak genes that play specific roles of evasion at the various stages of phagocytic uptake,
namely chemotaxis, opsonization, and phagocytosis. Comparing the regulation of the msa
gene on the individual factors in the two strains we observed the differential regulatory
behaviour by the msa gene. While in LAC, the msa mutation decreased only the clfA
levels in UAMS-1, the msa mutation decreased scn, clfA, spa, aur, and sak genes. In
addition, the msa gene increased aur levels in LAC, but in UAMS-1 it decreased the aur
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levels. Thus, we have not only observed the regulatory effect of msa on staphylococcal
immune evasion but also the strain-dependent variation of this regulation. In addition,
this study shows more evidence of the undeterred virulence of the community acquired
USA300 LAC strains.
Introduction
Staphylococcus aureus, we know causes a broad spectrum of infections that range
from superficial skin infections like folliculitis, and carbuncles, to more severe
endocarditis, and osteomyelitis. Additionally, S. aureus causes sepsis–a clinical
syndrome caused by entry of a pathogen into the blood stream whose severe clinical
manifestations are caused more by the host response to the pathogen than the pathogen
itself. Sepsis is characterized by the extensive inflammation along the path of the blood
stream which includes the liver, kidney, lungs, and the cardiovascular system on the
whole. Components of the S. aureus cells like peptidoglycan or the sheer presence of the
organism can trigger the release of cytokines, chemokines, and several inflammatory
mediators from the epithelial, endothelial, and other stimulated cells of the immune
system. Thus, in order to study the role of the msa gene in host persistence and metastasis
of infection we employed a murine sepsis model.
One of the most common causes of septicemia caused by post-surgical infections,
tissue trauma, and indwelling device-related infections is due to MRSA. Kreisel and
colleagues, while studying cases of bacteremia caused by USA300 and non-USA300
MRSA, pointed out that 25% of the cases were caused by USA300 MRSA, the skin and
soft tissue infection causing strains (Kreisel et al., 2011).
CA-MRSA strains have been observed to be more resilient than the Hospital
acquired MRSA (HA-MRSA) strains (Voyich et al., 2005). Voyich et al. pointed out that
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the increased virulence seen with USA300 strains was due to its ability to resist PMN
killing and cause host cell lysis possibly by the secreted and surface associated virulence
factors (Voyich et al., 2005; Diep et al., 2006; Foster, 2005). The hallmark of sepsis is the
severe host-associated damage caused by the immune system. This severity and longevity
is largely contributed by the persistence of the S. aureus CA-MRSA strains in the host.
This recalcitrance of CA-MRSA strains is still not completely understood. Studying the
behavior of msa in the sepsis model, phagocytic evasion, and infection dissemination we
hoped would help understand staphylococcal sepsis and virulence and shed light on the
recalcitrant pathogenicity of USA300 strains of S. aureus.
The msa gene has been seen to regulate several virulence factors and, thus,
proposed to play a vital role in virulence (Sambanthamoorthy, Smeltzer, & Elasri, 2006).
These virulence factors have also been observed to play a role in immune evasion.
Persistence of the pathogen in sepsis is largely contributed by the fact that the pathogen
can co-exist with the very immune factors that are trying to destroy it; in other words,
sepsis is possible by immune evasion. Thus, we investigated the role of msa in immune
evasion especially in the phagocytic evasion of the neutrophils, an important member of
the innate immune system. Here, we observed the role of msa in immunological
clearance of a CA–isolate (USA300 LAC strain) in comparison with a HA–clinical
isolate (UAMS-1). Employing these two strains, we studied if and how msa is one of the
regulators required for the evasion of the innate immune system and pathogen persistence
in a host.
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Methods and Materials
Strains and Growth Conditions
The isolates S. aureus UAMS-1 and that of USA300 lineage LAC were used for
this study. The msa gene was mutated by allelic replacement using pKOR-1 as described
in Chapter III. Complementation was achieved using pCN34. All cultures were grown in
TSB, Todd Hewitt Broth (THB), pooled human blood (Bioreclamation LLC), or horse
blood (Thermo Fisher Scientific Inc.) according to the experimental need at 37°C. The
complements of the msa mutants were selected by kanamycin (50 µg/ml).
Sepsis Model
Ten six-week old CD1 Swiss, outbred and immunocompetent mice (Charles River
Laboratories) where inoculated with 108 of wild type and mutant bacteria belonging to
the strains of USA300 LAC and UAMS-1, while control mice where inoculated with
PBS. These bacteria were administered in the tail intravenously in a 100 µl bolus (in
DPBS). Mice were monitored every 3rd hour for 24 hours followed by every 8th hour for
72 hours.
Blood Survival Assay
To assess the ability of S. aureus to survive in blood, the strains of S. aureus
USA300 LAC and UAMS-1 were inoculated in gender pooled whole human blood and
incubated at 37°C for 3 hours. Samples were collected at the 0 and 3rd hour, serially
diluted and plated. The colony forming units were counted after 18 hours of incubation at
37°C.
Growth Curve and Viability Assays
The bacterial strains were grown in TSB with a starting OD 600 = 0.05. Optical
density was measured every 30 min and plotted against time. For viability counts, cells
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were collected at the exponential phase of growth, serially diluted and plated on TSA.
The colony forming units were counted after 18 hours of incubation at 37°C.
Neutrophil Isolation
Neutrophils were isolated from blood obtained from healthy human volunteers.
An informed consent approved by the Institutional Review Board at The University of
Southern Mississippi was obtained from the volunteers. Briefly, Ficoll-Plaque PLUS (GE
Healthcare Biosciences) was mixed with freshly obtained whole blood at a ratio of 1:2.
This mixture was centrifuged at 400 x g for 30 – 40 min at 20°C. The layers containing
plasma, lymphocyte, and Ficoll were removed. The pellet was re-suspended to its original
volume. Equal volume of dextran/saline solution was added and mixed gently. This
suspension was allowed to stand at 25-45 degree angle for an hour at room temperature
followed by a 90 degree angle for 10 min. The suspension separated into two distinct
layers: the upper clear PMN layer and the lower layer. The PMN layer was carefully
transferred to a clean tube and spun down for 1500 rpm for 10 min. The resulting pellet
was re-suspended in 10 ml of 0.2% NaCl and the RBCs were lysed by gently pipetting up
and down for 1-2 min. Following this, 1.6% NaCl was added and spun down at 1500 rpm
for 10 min. The resulting PMNs were re-suspended in the desired volume of RPMI plus
10% Fetal Bovine Serum.
In vitro Phagocytosis Assay
Overnight cultures of S. aureus were normalized and grown for 100 min before
collecting them by centrifugation. These cells were washed using 1X PBS and opsonized
by incubating them with 10% orthologous human serum. Post opsonization, cells were
collected by centrifugation and re-suspended in RPMI 1640 medium. Neutrophils and
bacteria were mixed at a MOI of 1:100 and incubated at 37°C and 5% CO2. Samples
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were collected every 15 min for serial dilution and plating on Todd-Hewitt Agar.
Gentamicin (final concentration of 400 µg/ml) was added to kill the extracellular
bacteria. Neutrophils were collected by centrifugation, washed with PBS, and lysed in
37°C warm 0.02% Triton X containing PBS. This enables enumeration of the surviving
intracellular bacteria only. Colonies were counted after 15 hours of incubation at 37°C
and represented in a log plot as CFU/ml against time (minute).
Neutrophil Activation Assay
Neutrophils activation was assessed according to a modified version of the
protocol described by Gouwy and group (Gouwy, Struyf, Catusse, Proost, & Van
Damme, 2004). Briefly, post opsonization, cells were prepared similar to the
phagocytosis assay, mixed with bacteria and incubated for 10 minutes at 37°C and 5%
CO2. Samples were arrested by fixing them with 2% glutaraldehyde. Neutrophil
activation was assessed by the change of shape using a scanning electron microscope.
Scanning Electron Microscopy
After fixation with 2% glutaraldehyde, samples were washed with PBS and
serially dehydrated by consecutive incubations in 25%, 50%, 75%, 90%, and 100%
ethanol and HDMS. Samples were mounted onto specimen mounts and sputter coated
with platinum (5 mm). Images were acquired ona FEI Quanta 200 Scanning Electron
Microscopy (FEI Company, OR.)
Detection of the Immune Evasion Cluster
The immune evasion cluster (IEC) of USA300 and UAMS-1 was detected by
polymerase chain reaction (PCR) using the primers described by van Wamel and group
(van Wamel Rooijakkers, Ruyken, Van Kessel, & Van Strijp, 2006).
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Chemotaxis Assay
The Chemotaxis Assay will be conducted according the protocol described by
Durr et al., 2006. Migarated PMNs were stained with BCECF AM
(2′,7′‑bis‑(2‑carboxyethyl)‑5‑(and‑6)‑carboxyfluorescein- acetoxymethyl) and
enumerated by flow cytometry.
Clumping Factor Quantification Assay
ClfA binds to both soluble and insoluble fibrinogen and this binding was assayed
using fibrinogen as described by (Que et al., 2000). Briefly, two-fold serial dilutions of 1
mg/ml of fibrinogen (100 µl) were tested with 20 µl of cells washed in ice cold 0.9M
NaCl and resuspended in 1/10 of the initial volume in the same NaCl solution. Both
strains were mixed with the fibrinogen dilutions and incubated at 4ºC for 24 hours. The
wells were washed with 1X PBS thrice, fixed with 100% ethanol and stained with crystal
violet. The plate was allowed to dry after washing off the excess dye. The wells were
washed with 1X PBS. Hundred percent of alcohol was added to each well and allowed to
stand for 10 min for the dye to release itself from the cells. The absorbance of the
released dye was measured at 595 nm.
Protease Assay
Filter sterilized culture supernatants were collected from post exponentially
growing wild type and mutant strains of USA300 LAC and UAMS-1. Azocasein (3
mg/ml) prepared in Tris Buffered saline (pH 7.5) was added to the supernatant and
incubated in the dark at 37°C. After overnight incubation, trichloroacetic acid (50%) was
added to precipitate the un-degraded azocasein. Centrifugation separated the precipitate.
Protease activity was assayed by measuring the absorbance (340 nm) of the supernatant.
In order to quantify the metalloproteases, EGTA (1 mM) was employed.
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Hemolytic Assay
Hemolytic assay was conducted according to the protocol described in Chapter
III.
RNA Isolation and Real Time qPCR
RNA was isolated according to the protocol described by Sambanthamoorthy, et
al. (Sambanthamoorthy, Smeltzer, & Elasri, 2006). The primers used are described in
Table 9. Gyrase (gyr) was used as an endogenous control.
Table 9
Primers used for RT-qPCR

Gene

Primer Sequence (5’ to 3’)

clfA FP

CCT GAT GAG CCT GGT GAA AT

clfA RP

ATC GCT GCC AGA ATC TGA AC

chp FP

ACCGTTTCCTACAAATGA

chp RP

TTCAGCAAGTGGTGTATTC

scn FP

TTGCCAACATCGAATGAA

scn RP

CATTGCTTTTTGACCTGAA

map FP

AATAATAATGAAGCGTCTGC

map RP

CCTACTTTCAAATCGANAAC

sak FP

TGTAGTCCCAGGTTTAATAGG

sak RP

CGCGAGTTATTTTGAACC

spa FP

AGA TGA CCC AAG CCA AAG TG

spa RP

GCT TTC GGT GCT TGA GAT TC

Reference

(Sambanthamoorthy,
Smeltzer, & Elasri, 2006)
(Burian, Wolz & Goerke,
2010)
(Burian, Wolz & Goerke,
2010)
(Burian, Wolz & Goerke,
2010)
(Burian, Wolz & Goerke,
2010)
(Sambanthamoorthy,
Smeltzer, & Elasri, 2006)
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Table 9 (continued).

Primer Sequence (5’ to 3’)

Gene

hla FP
hla RP

GAA AGG TAC CAT TGC TGG
TCA

Reference

(Sambanthamoorthy,
Smeltzer, & Elasri, 2006)

AAG GCC AGG CTA AAC CAC TT
aur FP

GCA CTT TAT CAC CAG CAG CA

aur RP

TTG ACC GCA TCA CTC TTT TG

gyr FP

CAT TGC CAG ATG TTC GTG AC

gyr RP

CCG GTG TCA TAC CTT GTT CA

(Sambanthamoorthy,
Smeltzer, & Elasri, 2006)
(Sambanthamoorthy,
Smeltzer, & Elasri, 2006)

Western Blot
Cells were collected at the appropriate growth phase and washed with PBS before
lysing them with lysostaphin and glass beads. Lysates were loaded on SDS-PAGE gels
and immunoblots were tested for protein A, using anti-Spa antibodies (Sigma-Aldrich).
Defensin Susceptibility Assay
Susceptibility to defensins was assessed as described by Jin et al. (2004). Briefly,
cultures were grown in THB and normalized to an OD of 0.05. To these cultures Human
Neutrophil Protein-1(HNP-1) and HNP – 2 (5 µg/ml) was added separately. Viability was
tested by collecting samples after 6 hours of incubation at 37°C. Samples collected were
serially diluted and plated on horse blood agar. Colonies were enumerated after 18 hours
of incubation at 37°C.
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Results
msa is Required for Persistence and Dissemination of S. aureus
Persistence and dissemination of the wild type and msa mutants of S. aureus
strains were studied using a murine sepsis model. No difference was seen between the
wild type and the msa mutants of LAC strains (Figure 21). On the other hand there was a
decrease in bacterial load in the lungs of the mouse infected with the msa mutant of
UAMS-1 compared to the wild type (Figure 22).
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Figure 21. Bacterial load of wild type and mutant strains of S. aureus LAC strains in the
various organs of the murine sepsis model. In these box and whisker graphs, the solid line
is the median and the + is the mean. The boxes represent the interquartile range (IQR).
No statistical significance seen (Mann Whitney test): P<0.05.
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Table 10
Statistical Significance by Mann Whitney test of LAC strains in the sepsis model

Organ

Significance by Mann Whitney test

Lungs

0.362

Kidneys

0.362

Brain

0.356

Heart

0.524

Spleen

0.798

Liver

0.700
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Figure 22. Bacterial load of wild type and mutant strains of S. aureus UAMS-1 strains in
the various organs of the murine sepsis model. In these box and whisker graphs, the solid
line is the median and the + is the mean. The boxes represent the interquartile range
(IQR). Statistical significance (Mann Whitney test) seen only in the case of Lungs:
P<0.05.
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Table 11
Statistical Significance by Mann Whitney test of UAMS-1 strains in the sepsis model

Organ

Significance by Mann Whitney test

Lungs

0.024

Kidneys

0.670

Brain

0.645

Heart

0.362

Spleen

0.210

Liver

0.188

Deletion of msa Influences Survival in Blood
Mutant and wild type strains of USA300 LAC and UAMS-1 were tested for their
ability to survive in gender pooled whole human blood. Mutation in USA300 LAC
increased its ability to survive (Figure 23) while in UAMS-1 it decreased the survival in
blood (Fig. 24).When comparing the wild types of the two strains of USA300 LAC and
UAMS-1, clearly the osteomyelitis strain UAMS-1 survived better and multiplied more
than the skin and the SSTI causing USA300 LAC.
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Figure 23. Increased percentage survival of the msa mutants of S. aureus LAC strains in
whole human gender-pooled blood compared to the wild type and complement strains.
Deletion of the msa gene revealed increased percentage survival in the msa mutants of S.
aureus LAC strains.

Figure 24. Decreased percentage survival of the msa mutants of S. aureus UAMS-1
strains in whole human gender-pooled blood compared to the wild type and complement
strains. Deletion of the msa gene revealed decreased percentage survival in the msa
mutants of S. aureus UAMS-1 strains.
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Figure 25. Growth Curve of UAMS-1 strains showing no effect on the growth of UAMS1 strains on deleting the msa gene.

Figure 26. Growth Curve of LAC strains showing no effect on the growth of LAC strains
on deleting the msa gene.
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Figure 27. Viability Assay of the strains S. aureus LAC and UAMS-1 showing no change
in viability on deleting the msa gene.

The effect of msa on growth and viability was also tested (Figure: 25-27). Neither
strain showed a difference between the wild type and mutant. This, ruled out the
possibility of a growth defect caused by the mutation and confirmed that the survival rate
of the mutants in blood was influenced by the interactions of the bacteria with the
components of the whole blood. In the presence of blood, the msa mutant of UAMS-1
was unable to survive as well as the wild type or the strains of LAC either. These results
suggest that msa plays an important role in determining clearance or persistence of S.
aureus in the bloodstream of the host. However, this role was observed to differ across
the two genetic backgrounds tested.
msa Does Not Contribute to Preventing Chemotaxis
Chemotaxis assay using the supernatant of strains of LAC and UAMS-1 did not
reveal any significant difference in attracting PMNs as seen in Figure 28. Thus, we have
no evidence of msa preventing chemotaxis.
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Figure 28. Percentage of PMN migrating in response to the supernatant of the strains of
LAC and UAMS-1. No significant change was observed in the chemotaxis of neutrophils
in response to the supernantants of S. aureus strains.
msa Prevents Neutrophil Activation
Neutrophils are spherical in shape until they are activated by the presence of a
pathogen, then they branch out to form pseudopodia and invagination cups to engulf the
pathogen. After incubating the neutrophils for 10 minutes with the strains of LAC and
UAMS-1, only the neutrophils in the presence of msa mutants of UAMS-1 showed
extensive branching, and the UAMS-1 complements showed shorter branching. Thus,
based on the morphological change, we report that the mutants increased the activation of
neutrophils. All other strains retained their spherical shape.
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Figure 29 a. Scanning Electron Microscopy showing the spherical neutrophils in the
absence of S. aureus. Neutrophils in the absence of S. aureus were used as a negative
control to reveal the spherical shape of inactive neutrophils.

.
Figure 29 b. Scanning Electron Microscopy of neutrophils showing no change in shape in
the presence of S. aureus LAC strains
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Figure 29 c. Scanning Electron Microscopy of neutrophils comparing the extent of
branching of neutrophils in the presence of UAMS-1 strains.
msa contributes to the outcome of PMN attack
Neutrophils are the primary components of the innate immune system whose
rapid, un-biased response clears pathogens from the host system. We tested the effect of
this non-specific clearance by neutrophils on the mutant and wild type strains of USA300
LAC and UAMS-1 on engulfing the cells (Figure 30). The mutant in UAMS-1 showed
decreased intracellular counts when rescued from the neutrophils (Figure 32). In some
experimental runs (not shown here), the UAMS-1 mutant showed zero CFUs reflecting
death and eradication of the mutant by the neutrophils. Thus, mutation of msa in the
UAMS-1 strains somehow made these strains susceptible to immunological clearance by
neutrophils compared to the wild type UAMS-1. The same mutation in LAC strains
showed no change in the intracellular survival (Figure 31). The mutant and wild type
strains of USA300 LAC survived equally well when exposed to phagocytosis by human
neutrophils.
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A

B

Figure 30. TEM image showing the intracellular presence of S. aureus (A) LAC strains
and (B) UAMS-1 in human neutrophils.

Figure 31. Phagocytosis Survival Assay of S. aureus LAC strains showing no difference
in intracellular survival on deleting the msa gene.

Figure 32. Phagocytosis Survival Assay of S. aureus UAMS-1 strains showing a decrease
in intracellular survival on deleting the msa gene
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msa regulates the Immune Evasion Cluster
USA300 strains of S. aureus were observed to carry bacteriophage-encoded
immune evasion cluster (IEC) type B (Highlander et al., 2007). The IEC type in UAMS-1
was unknown. Based on the classification described by van Wamel (2006) and our results
from the detection of the sea, sak, chp and scn by PCR (Figure 33), we report UAMS-1 to
be IEC type A. RT-qPCR analysis showed that deletion of msa reduced the expression of
scn and sak in UAMS-1 (Table 12). Thus, we show that msa regulates IEC, a mobile
genetic element of UAMS-1 strains.

Figure 33. Detection of sea, sak, chp and scn genes in S. aureus LAC wild type (1),
LACΔmsa (2), LAC complement (3), UAMS-1 (4), UAMS-1Δmsa (5) and UAMS-1
Comp (6). S. aureus LAC strains bear the IEC type A and UAMS-1 the IEC type B.
msa Regulates Phagocytic Evasion Factors
Transcript analysis revealed several evasion factors to be regulated by the msa
gene (Table 12) and, interestingly, the regulation differed between the staphylococcal
strains of LAC and UAMS-1. In LAC, deletion of msa resulted in decreased expression
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of clfA and increased expression of aur. In UAMS-1, there was a decrease in expression
of clfA, aur, scn, and spa.
Table 12
Relative fold change in the expression of the genes required for phagocytic evasion on
deleting the msa gene.

Gene

LAC

UAMS-1

chp

- 2.56¥

3.23

scn

- 1.36

- 6.06¥

sak

1.89

- 5.5¥

clfA

- 10.96¥

- 41.75¥

spa

1.56

- 4.04

aur

8.12¥

- 4.44¥

hla

- 0.6

*

sarA

- 6.54¥

- 6.03¥

agrB

-2.52¥

- 6.28¥

Note. ¥ - p-value less than 0.05; * - Naturally mutated.

msa Prevents Opsonization
We tested several factors previously known to be employed by S. aureus to
prevent opsonization and/or opsonophagocytosis to study if msa regulated any of them.
The factors we tested were ClfA (Josefsson, Hartford, O’Brien, Patti, & Foster, 2001;
Palmqvist et al., 2004, McAdow et al., 2011), protein A (Peterson, Verhoef, Sabath, &
Quie, 1977; Gemmell, Tree, Patel, O’Reilly, & Foster, 1991; Palmqvist, Foster,
Tarkowski, & Josefsson, 2002; Patel, Nowlan, Weavers, & Foster, 1987; Uhlen et al.,
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1984), and capsular proteins (Nilsson et al., 1997; Thakker, Park, Carey, & Lee, 1998;).
The regulatory effect of msa on the expression of these factors was studied by analyzing
the transcripts and assaying for each of these factors.
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Figure 34. Quantification of ClfA levels based on the ability to bind to fibrinogen
revealed reduced ClfA levels in the mutants of S. aureus LAC
Owing to the ability of ClfA to bind to fibrinogen, levels of surface exposed ClfA
was measured by quantifying the cells bound to the range of fibrinogen concentrations.
Deletion of msa in LAC and UAMS-1 showed a significant drop in fibrinogen-bound
cells (Figure 34 and 35) indicating reduced levels of surface associated ClfA proteins.
This observation was further supported by the reduced transcription of clfA seen in
transcript analysis (Table 12). Thus, we have evidence that the msa gene is required for
preventing opsonization by maintaining the levels of ClfA in S. aureus. Analyzing the spa
transcripts and Spa protein levels using western blots showed no difference between wild

62
type and msa mutant suggesting that in both LAC and UAMS-1 strains (Figure 36) msa
does not regulate the protein A.
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Figure 35. Quantification of ClfA levels based on the ability to bind to fibrinogen
revealed reduced ClfA levels in the mutants of S. aureus UAMS-1.

Figure 36. Western Blot with anti-Spa antibodies showing no difference in Spa levels
between the wild type and mutant strains of LAC and UAMS-1.
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When testing staphylokinase transcript levels in mutant and wild type strains,
there was a -5.5 decrease in sak expression in UAMS-1 strains whereas in USA300 LAC
there was no significant increase or decrease in sak levels (Table 12).
Taken together, these results indicate that of the factors tested msa regulates
evasion of opsonization by regulating the clfA levels.
msa Does Not Aid in Escaping from the Phagocyte
Strains of S. aureus LAC express the α-hemolysin (encoded by hla) when
phagocytized which aids in the escape of the bacteria by the lysis of PMN (Kubica et al.,
2008, Pang et al., 2010). Hemolysin expression and toxicity was assayed. Cells were
collected at an early stationary phase of about OD600 nm = 3.5 to analyze the transcript
levels. Deletion of msa in LAC strains showed no significant change in hla transcription.
The supernatant collected from the same time point was used for hemolytic assay, which
showed no difference in activity between the wild type and mutant (Figure 37). UAMS-1
has an inherent mutation in the hla gene, which rules out the possible contribution it
could have to lysis and phagocytic escape (Weiss et al., 2009).

Figure 37. Hemolytic activity showing no difference between the mutant and wild type
strains of S. aureus LAC strains
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msa Contributes to the Intracellular Phagocytic Survival
Deletion of msa in S. aureus LAC increased the levels of extracellular proteases
(Figure 38). Differential assaying to identify individual classes of proteases revealed
aureolysin to be the most abundantly increased on deleting the msa gene. Supporting this
finding, RT-qPCR also revealed an increase in aur expression (Table 12) on deleting the
msa gene. In UAMS-1 deletion of msa, showed reduced transcripts (Table 12). This
decrease in protease activity although was not seen in the protease assay (Figure 39). This
suggested that msa contributes to regulation of intracellular survival via the protease
levels although the extent of influence on the intracellular survival differs among strains
of S. aureus.
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Figure 38. Protease activity of S. aureus LAC strains using azocasein as a substrate
showed increased protease activity on deleting the msa gene in S. aureus LAC strains.
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Figure 39. Protease activity of S. aureus UAMS-1 strains using azocasein as a substrate
showed no difference on deleting the msa gene in S. aureus LAC strains.
As shown earlier, the deletion of the msa gene decreased transcript levels of
staphylokinase by a – 5.5 fold in UAMS-1 but did not influence the same in LAC strains
(Table 12). Jin et al (2004), showed the neutralizing effect of the staphylokinase on
human defensin peptides. Hence, the susceptibility of the strains LAC and UAMS-1 were
assessed using human defensing peptides. Mutants of msa did not show an increase or
decrease in susceptibility to HNP (Figure 40-41).

Figure 40. Mutation of msa in LAC did not influence susceptibility of S. aureus LAC
strains to HNP-1.

66

Figure 41. Mutation of msa in UAMS-1 did not influence susceptibility of S. aureus
UAMS-1 strains to HNP-1.
Discussion
Most invasive infections of S. aureus have been observed to be accompanied by
sepsis (Liu et al., 2011). Klevens et al., in 2008 reported that less than half of the sepsis
patients under intensive care succumbed to death (Klevens et al., 2008). Infection in the
blood provides a convenient route of infection dissemination of bacteria like S. aureus. In
order to disseminate to and colonize the various organs of the host, S. aureus should be
able to share the path of the hematogenous route with phagocytes, complement proteins,
and other members of the immune system that are constantly clearing the host system of
such foreign entities. Thus, in order to study the role of msa in host persistence and
infection dissemination a sepsis model was employed.
Organs have their own organ-specific immune factors that defend the organs from
an infection. The liver plays an important role in bacterial clearance (Benacerraf,
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Sebestyen, & Schlossman, 1959; Brandborg & Goldman, 1990; Mackaness, 1962; Mims,
1987). When septicemic blood flows through the liver, the bacteria adhere on to the
hepatocytes via an interaction between their carbohydrate receptors and lectins
respectively. Immigrant polymorphonuclear neutrophils (PMNs) attracted to these
hepatocyte bound bacteria engulf and phagocytize them (Ofek & Sharon, 1984; Perry &
Ofek, 1984, Perry, Keisari, & Ofek, 1985). PMNs are important and abundant players of
the innate immune system that prevent the propagation of bacteria in the liver (Gregory et
al., 1996). Spleen also plays an important role in bacterial clearance and detoxification of
toxins (Altamura et al., 2001). Phagocytosis is one of the most important modes of
bacterial clearance, which is accomplished by the splenic macrophages, marginal zone
macrophages of the spleen, and alveolar macrophages of the lungs. The spleen receives
200-300ml/min/100-150g organ of blood flow in human and at the site of its red pulp it
purifies the blood of old and damaged RBCs along with any cell debris (Timens, 1991).
Blood also flows through the B- and T-lymphocyte containing white pulp of the spleen
and exposes the antigens carried by the blood to antibody production. These antibodies
aid in opsonization of bacteria and its subsequent clearance from the blood (van den
Dobbelsteen et al., 1993).
The murine sepsis model used to study the regulation of infection dissemination
by msa showed varying results in the two strains used: LAC and UAMS-1. Deleting the
msa gene in the genetic background of LAC did not alter the dissemination of infection
via the blood stream to the organs. Bacterial load in the lungs although was reduced in
the murine models infected with the mutant strains of UAMS-1as compared to the wild
type. This finding suggests several possibilities. Firstly, in the strains of LAC the
regulation of infection dissemination by the msa gene is overpowered by a stronger

68
global regulator or this regulator may not be completely under the regulation of the msa
gene. In UAMS-1 the same possibilities could be the case although the extent of the
influence of the regulation by msa could be more than that seen in LAC strains. Second
and most importantly, the sepsis model is that a murine organism. Hence, the findings of
the murine sepsis model may not truly reflect the true behavior of the strains, as the
virulence factors of S. aureus are human specific (Rooijakkers et al., 2005c; Serruto et
al., 2010).
The blood stream, which is the carrier of the infection, also harbors the factors
that kill microbes. We assessed the ability of the wild type and mutants to survive in
gender-pooled whole human blood. When the strains of S.aureus were co-incubated with
whole human blood, the mutant of LAC survived better than the wild type (Figure 23),
while in the case of UAMS-1, the wild type survived better than the mutant (Figure 24).
These results were in agreement with the results obtained from the phagocytosis survival
assay (Figure 31 and 32).
Neutrophils in the presence of chemotactic factors undergo changes in shape like
blebbing and branching of extensions. According to Guowy et al., (2004), the
chemotactic factor interleukin -8 was responsible for blebbing while IL-8 and monocyte
chemotactic protein – 3 (MCP-3) was responsible for the extensions from the neutrophils.
Neutrophils exposed to S. aureus strains for 10 minutes showed blebbing in all UAMS-1
strains but the highest level of extensions were observed in UAMS-1 mutants. This
indicated that UAMS-1 mutants induced the highest levels of chemotactic factors.
Comparing our observations with that of Guowy et al., (2004) we suggest that these
factors could be IL-8 and MCP-3. Although we observed increased chemotactic response
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from the neutrophils exposed to UAMS-1 mutants, the chemotaxis assay did not show an
increase in chemotaxis as compared to the wild type.
In the phagocytosis survival assay, the mutant in UAMS-1 showed increased
susceptibility to phagocytosis (Figure 32), but in LAC the mutation showed no change in
the susceptibility to phagocytosis. Thus, we have evidence of the regulatory influence of
the msa gene in immunological clearance by neutrophils and persistence in the
bloodstream. This observation also indicates the importance of the msa gene in
combating the attack of the innate immune system on S. aureus.
The susceptibility or resistance observed in the blood and phagocytosis assay,
however, was not in congruence with the results of the sepsis model. Decreased bacterial
counts were observed only in the lungs when infected with UAMS-1 mutants. There was
no significant decrease in survivors of the UAMS-1 mutants in the other organs that
utilize phagocytosis for clearing the blood supplied microbes. This we assume is due to
the high number of phagocytes and efficient organ-specific phagocytosis that clears the
wild type and the mutant without any significant discrimination. Another important factor
to take into consideration is that the animal model used was that of a murine species.
These results may not coincide with the results obtained from the experiments conducted
with blood and neutrophils obtained from humans.
Sambanthamoorthy et al. in 2006 showed that the msa gene regulated other global
regulators like sarA and agr (Sambanthamoorthy, Smeltzer, & Elasri, 2006). When
analyzing the effect of the msa mutation on the expression of these global regulators in
the strains of LAC, RNA III levels decreased to a smaller extent (- 2.52 fold) as
compared to the decrease seen in the UAMS-1 strains (- 6.5 fold). Intracellular survival
and escape of the S. aureus USA300 strains from the PMN is strongly regulated by the
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agr system (Pang et al., 2010). Thus, there is a possibility that the down-regulation of
RNA III observed in LAC on deleting the msa gene, may not have reduced the agr levels
to a degree that will make the LAC strains susceptible to immunological clearance. Thus,
the msa mutant in LAC retained the ability to survive undeterred in the host. This
reasoning could explain the findings of the animal model (ignoring the difference
between organisms), blood survival, and neutrophil assays.
On the other hand, in UAMS-1 there have been no previous studies indicating the
key global regulator involved in intracellular survival in PMNs. The results obtained in
our study, revealing increased susceptibility and clearance in the phagocytosis and blood
survival assays, indicate a possibility of agr also being involved in PMN survival of
UAMS-1 strains. Since, the mutation of msa reduced the RNAIII levels in UAMS-1 more
than it did in LAC, we could assume that this is the reason why mutation of msa
weakened the strain of UAMS-1 but not LAC.
The msa gene also regulates the sarA levels in S. aureus (Sambanthamoorthy,
Smeltzer, & Elasri, 2006). Deleting the msa gene reduced the sarA levels to a -6.54 and a
-6.03 fold in the LAC and UAMS-1 strains. Owing to the fact that in UAMS-1, the key
regulator required for PMN survival has not been shown yet, the 6 fold reduction seen in
sarA levels could also contribute to PMN survival as sarA is an important global
regulator. Until the key regulator of UAMS-1 required for surviving a PMN attack is
identified, we cannot safely place our assumptions on the regulation of msa through by
either agr or the sarA systems.
The staphylococcal feat of phagocytic evasion can be divided into four levels:
prevention of chemotaxis, prevention of opsonization, phagocytic escape (postengulfment), and intracellular survival (Figure 42). Testing for the various factors
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contributing to the illustrated levels of preventing phagocytosis, msa was observed to
regulate the levels of clumping factor A (ClfA), staphylococcal complement inhibitor
(SCIN), staphylokinase (Sak), protein A (Spa), and aureolysin (Aur) in the
staphylococcal strains. However, depending on the strain, the combination of factors
influenced by the gene regulation by msa differs.
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Figure 4.2. Schematic representation of the four levels of phagocytic evasion by S.
aureus. Staphylococcal factors of immune evasion that contribute to the various stages
are also enlisted in this representation.
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In the strains of LAC, deletion of the msa gene decreased the ClfA levels and
increased the Aur levels, which seems conducive to the resistance to immunological
clearance. The decrease in the ClfA levels could have increased the probability of
opsonophagocytosis. Phagocytic uptake appears to be instrumental to resisting the
immune system as the staphylococcal cells, once engulfed, have the ability to survive
within the phagocyte owing to the increased levels of aureolysin. Thus, the mutation in
LAC provided a safe haven from the non-phagocytic and phagocytic attacks of the
immune system. In addition, the intracellular survival in the circulating neutrophils could
have also served as a vehicle of dissemination. These assumptions based on the ClfA and
Aur levels explain the undeterred survival of the mutants of LAC in the sepsis model,
blood survival, and phagocytosis assays. Thus, msa in the strains of LAC is required for
maintaining the levels of ClfA and Aur to evade the innate immune system.
In UAMS-1, deleting the msa gene decreased the transcription of SCIN, ClfA,
Spa, Sak and Aur. Assaying for ClfA levels clearly showed a decrease in surface
associated levels of ClfA on mutating the msa gene. However, phenotypic assays for
studying levels of Spa and Aur showed no difference. We, thus, suggest that the
significant reduction in clfA levels in the mutant could have contributed to the increased
probability of opsonophagocytosis. However, unlike in the case of the msa mutant in
LAC strains, phagocytized mutants of UAMS-1 do not have high levels of Aur or an
undeterred level of Sak that support intracellular survival in PMN. Thus, the mutant of
msa in UAMS-1 is susceptible to clearance by the neutrophils. This, we propose, could
have contributed to the increased susceptibility seen in blood survival and phagocytosis
assays. Reduced transcription of SCIN was observed in the mutants of UAMS-1,
although no difference was observed in the chemotaxis assay. Thus, in UAMS-1 the
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regulation by the msa gene is required for upregulating the clfA, spa, sak, aur and scn
levels to resist the innate immune system and to disseminate via intracellular survival in
neutrophils.
Thus, we have evidence of the role of the msa gene in the regulatory network
governing the susceptibility or resistance to immunological clearance and exploitation of
PMNs for infection dissemination-a remarkable characteristic of S. aureus. The extent of
regulation by the msa gene, however, seems to differ across strains. In addition, we report
for the first time the regulatory influence of msa on the IEC, a mobile genetic element.
There are several factors that we suggest could hold a plausible explanation to the straindependent behavior of msa. Some of them include (a) the sequence variation of a gene
(virulence factor or gene regulator) across the strains of S. aureus that could influence the
regulatory effect of msa on that particular gene, (b) inherent single nucleotide
polymorphisms that could render a gene inactive or weak, (c) acquisition of mobile
genetic elements, and (d) redundancy of virulence factors that could mask the effect of
msa mutation as seen in the case of LAC.
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CHAPTER V
REGULATION OF PROTEASES BY MSA IN BIOFILM
AND NON-BIOFILM CONDITIONS
Abstract
Staphylococcal biofilms have been a growing problem in the healthcare sector
due to the resistance to antimicrobial treatment options, repetitive surgical interventions
and containment of infection. Detachment of cells from a biofilm not only plays an
important role in biofilm development, but also in the dissemination of infection. The
msa gene of S. aureus has been previously observed to down-regulate proteases.
Extracellular proteases of S. aureus are very important virulence factors that play an
important role in several stages of the staphylococcal infection and especially in
dissemination. Hence, we studied the effect of msa on the staphylococcal proteases of the
community-acquired MRSA strain USA300. Interestingly, deletion of msa increased
protease levels when the cells were growing under non-biofilm, planktonic conditions,
but in biofilm conditions the mutation had no effect on the proteases. This revealed an
environment-dependent variation of the regulation by the msa gene. Thus, the msa gene
might play a more significant role in non-biofilm infections than in biofilm infections of
S. aureus.
Introduction
Proteases are extracellular enzymes released by Staphylococcus aureus during the
post exponential phase of growth. S. aureus produces three important classes of proteases
namely metalloprotease (Aureolysin), serine protease (V8 protease) and the cysteine or
thiol proteases (Arvidson, 2000).
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These proteases are translated as proenzymes, which are cleaved in order to
activate them. The ssp operon contains sspA, sspB, and sspC. Aureolysin cleaves the
proenzyme form of serine protease (Drapeau, 1978).The SspA thus active in turn is
required for cleavage and activation of SspB, a cysteine protease (Karlsson & Arvidson,
2002; Rice, Peralta,Bast, deAzavedo, & McGavin, 2001). SspC (also known as
staphostatin B) formed is a specific inhibitor of aur. This ssp operon is positively
regulated by agr and negatively regulated by σB and the regulator sarA (Blevins et al.,
2002; Karlsson & Arvidson, 2002; Shaw et al., 2004; Tsang, Cassat, Shaw, Beenken, &
Smeltzer, 2008). These serine proteases play important roles in processing cell surface
proteins like fibronectin binding protein (FnBP) and protein A (Karlsson & Arvidson,
2002; McGavin, Zahradka, Rice, & Scott, 1997) and in immune evasion (Burlak et al.,
2007). Several such surface proteins, namely the biofilm-associated protein Bap
(Cucarella et al., 2001), protein A (Merino et al., 2009), FnBP (O’Neill et al., 2008), and
SasG (Corrigan, Rigby, Handley, & Foster, 2007) play vital roles in biofilm formation.

Figure 43. Stages of biofilm development of S. aureus. S. aureus form biofilms through
the stages of attachment onto a surface, growth and formation of biofilm towers and
detachment of biofilm (Dirckx & Stoodley, 2003).
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Analyzing the constituents of biofilms, several studies showed that along with the
conglomeration of cells, biofilms had an extracellular matrix consisting of proteins, DNA
(Rice et al., 2007), and/or polysaccharide intercellular adhesion PIA/PNAG encoded by
the icaADBC operon (Cramton, Gerke, Schnell, Nichols, & Gotz, 1999). To weaken
these recalcitrant biofilms, degrading agents specific for these individual constituents
were added (Boles & Horswill, 2008; Izano, Amarante, Kher, & Kaplan, 2008; Mann et
al., 2009). These biofilms formed by several clinical isolates have been observed to be
polysaccharide dependent or even independent (Boles, Thoendel, Roth, & Horswill,
2010; Lauderdale, Boles, Cheung, & Horswill, 2009; Lauderdale, Boles, Morcuende, &
Horswill, 2010; O’Neill et al., 2007).
As seen previously in S. aureus COL, deletion of the msa gene in the new and
virulently emerging strain USA300 LAC increased the protease levels
(Sambanthamoorthy, Smeltzer, & Elasri, 2006). Deletion of the msa gene was also
observed to weaken the biofilm formed by S. aureus COL (Sambanthamoorthy,
Schwartz, Nagarajan, & Elasri, 2008). This led us to question if the weakening of
biofilms formed by the msa mutant was due to the increased protease levels. Here, in this
study, we tested the effect of protease regulation by the msa gene in biofilm and nonbiofilm conditions, to understand the relationship of msa and proteases.
Materials and Methods
Protease Assay
Protease activity was quantified as described in Chapter III. In order to quantify
the individual classes of proteases, the respective inhibitors were added. The protease
activity for each class was assessed by adding specific protease inhibitors. EGTA (1
mM), PMSF (200 µM), and E-64 or 20 µM L-trans-epoxy-succinyl-leucylamido (4-
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guanidino) butane was employed to inhibit metalloproteases, serine proteases, and thiol
proteases, respectively. Proteases from biofilm effluents were also assessed similarly.
RNA Isolation and Real-time PCR
RNA was isolated from cells grown in planktonic and biofilms conditions using
Rneasy kit (Qiagen Inc.). Transcript levels of the proteases were determined using realtime quantitative PCR (RT-qPCR) with the primers described in Table 13. As an
endogenous control gyr (gyrase) primers were used.
Table 13
Primers for RT-qPCR

Gene

Primer Sequence (5’ to 3’)

aur FP

GCA CTT TAT CAC CAG CAG CA

aur RP

TTG ACC GCA TCA CTC TTT TG

ssp FP

TCA AGC AAA CAG CAA ACA CC

ssp RP

TTT GCG TGT TCA CGT TGT TC

gyr FP

CAT TGC CAG ATG TTC GTG AC

gyr RP

CCG GTG TCA TAC CTT GTT CA

Reference

(Sambanthamoorthy,
Smeltzer, & Elasri, 2006)
(Sambanthamoorthy,
Smeltzer, & Elasri, 2006)
(Sambanthamoorthy,
Smeltzer, & Elasri, 2006)

Biofilm Detachment Assay
Biofilms were grown in flow cells (Figure 44) following the methods described
by Beenken, Blevins, & Smeltzer, (2003) and Beenken et al. (2004). Briefly, microtiter
plates (Thermo Fisher Scientific Inc.) or flow cells (Stovall Life Science Inc.) were
coated with human plasma and incubated at 4ºC overnight before inoculating the biofilm
systems. Inoculums were prepared by normalizing the overnight cultures and added or
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injected into the microtiter plate and flow cell respectively. Incubation was conducted at
37ºC. Flow cells were pumped with TSB (supplemented with NaCl and glucose) at a flow
rate of 0.5 ml/min (Figure 44). Samples were collected periodically and analyzed for
protease activity and detachment.
Effluents from flow cells were collected, serially diluted, and plated on TSA
plates to enumerate the cells and, thus, determine the rate of detachment of biofilms cells.
For quantifying protease activity, effluents were filter sterilized and subjected to the
protease assay as described above.

Figure 44. Flow cell set up employed for in vitro growth of biofilms of S. aureus. This
set up consists of media pumped into the flow cell system using a peristaltic pump, a flow
cell unit for the growth of biofilms, and a waste container.
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Results
msa Does Not Contribute to Biofilm Detachment
Deletion of the msa gene did not affect the detachment of biofilm cells as seen in
Figure 45. The number of cells detaching from the biofilms of wild type and mutant were
equal at all the time points tested. This also revealed that the detached cells were all
viable and hence the degree of metastatic infection was not influenced by the msa gene.

Figure 45. Biofilm Detachment Assay showing no difference in biofilm detachment on
deleting the msa gene from S. aureus LAC strains.
Differential Regulation of Proteases
Deletion of the msa gene increased the protease levels as observed by the protease
assay (Figure 46) and the transcript analysis (Table 14). Clearly, this indicates the vital
role of msa in maintaining the protease levels in S. aureus LAC strains. However, when
the very same strains were grown under biofilm conditions, the deletion of the msa gene
did not increase protease levels (Figure 46 and Table 14-16). Deletion of msa showed no
change in the transcript levels of proteases in cells of the biofilms and that of the
detaching cells.
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Figure 46. Protease activity of non-biofilm cells of S. aureus LAC strains using
azocasein. Individual classes of proteases were assessed by the addition of specific
inhibitors to the sample . Serine protease was inhibited by PMSF, aureolysin by EGTA
and cysteine protease by E-64.

Table 14
Relative Expression of proteases

Gene

Class of Proteases

Fold Change

aur

Metalloprotease

8.12

ssp

Serine Protease and Cysteine Protease

8.28

(Co-transcribed)
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Figure 47. Protease Activity of the biofilm effluents of LAC strains of S. aureus
Table 15
Relative Expression of proteases in 50 hr mature biofilm.

Gene

Class of Proteases

Fold Change

aur

Metalloprotease

1.15

ssp

Serine Protease and Cysteine Protease

1.17

(Co-transcribed)

Table 16
Relative Expression of proteases in detached cells from 50 hr mature biofilm.

Gene

Class of Proteases

Fold Change

aur

Metalloprotease

-1.07

ssp

Serine Protease and Cysteine Protease

1.26

(Co-transcribed)
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Discussion
Proteases play a very vital role in the virulence of S. aureus. They are not only
virulence factors by themselves but also agents of regulation. In this work, it is evident
that msa regulates these proteases, as deletion of the msa gene increased the overall
protease activity and the transcript levels of aureolysin and serine proteases. Three
classes of proteases were individually quantified to study the role of msa on each of them.
The msa gene as seen in the detachment assay does not regulate the detachment of
biofilms of LAC strains. Our observations have shown that under the biofilm conditions,
the protease levels did not increase on deleting the msa gene, suggesting that although
msa regulates proteases, under biofilm conditions the scenario of regulation might be
different. The msa gene may not have control over proteases under biofilm conditions
and/or there is another regulating factor that controls and maintains the protease
production under biofilm conditions. This regulator may or may not be under the
regulation of the msa gene. Clearly, the regulation of proteases under biofilms seems
more complex than it appears under non-biofilm conditions. If proteases played a role in
biofilm detachment in LAC strains, it would have possibly hinted at the constituents of
the biofilms formed by LAC to be proteinaceous. At this point, we have no evidence of
the nature of the constituents of the biofilms formed by the staphylococcal strains of
LAC.
The effects of the regulation by the msa gene seem to be influenced by the
environment in which the staphylococcal cells are present. This could explain why we see
an effect on the protease regulation in non-biofilm (planktonic) cells and not in cells of
the biofilm. Thus, we conclude that the msa gene regulates proteases and might be
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important in non-biofilm infections, but in biofilm infections the msa gene might be overpowered or insignificant in regulating the proteases.

84
APPENDIX
IRB APPROVAL LETTER
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